Dual target gene therapy to EML4-ALK NSCLC by a gold sorted by
relevance

Admin27.07.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

8600
Admin08.08.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

7109
Admin24.07.2021

Yuxi Lius research works | China Pharmaceutical

8205
Admin13.09.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

2402
Admin31.08.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

9509
Admin24.07.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

703
Admin26.07.2021

Yuxi Lius research works | China Pharmaceutical

3502
Admin19.09.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

6803
Admin29.07.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

807
Admin01.10.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

Admin14.07.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

4308
Admin18.08.2021

The properties of the RGD@siRNA@DOX@HAuNs drug carrier

9705
Admin11.09.2021

Yuxi Lius research works | China Pharmaceutical

3505
Admin13.09.2021

Dual target gene therapy to EML4-ALK NSCLC by a gold

37010
Admin07.09.2021

The mechanism of treatment target selection and the

4504
Admin04.08.2021

Treatment efficacy of RGD@siRNA@MPA@HAuNs at a cellular

5302
Admin31.08.2021

Volume 8, Issue 10

4601
Admin17.07.2021

Volume 8, Issue 10

604
Admin08.09.2021

Liping TANG | Profesor | Ph.D. | University of Texas at

909
Admin01.08.2021

Liping TANG | Profesor | Ph.D. | University of Texas at

3403
Admin25.09.2021

Volume 8, Issue 10

60010